• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻求医疗卫生领域经济模型责任透明度的解决方案。

Finding Resolution for the Responsible Transparency of Economic Models in Health and Medicine.

作者信息

Padula William V, McQueen Robert Brett, Pronovost Peter J

机构信息

*Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD †Center for Pharmaceutical Outcomes Research, Skaggs School of Pharmacy & Pharmaceutical Sciences, University of Colorado, Aurora, CO ‡Departments of Anesthesiology & Critical Care Medicine and Surgery, Johns Hopkins Medicine, Baltimore, MD.

出版信息

Med Care. 2017 Nov;55(11):915-917. doi: 10.1097/MLR.0000000000000813.

DOI:10.1097/MLR.0000000000000813
PMID:29028755
Abstract

The Second Panel on Cost-Effectiveness in Health and Medicine recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses has a number of questions unanswered with respect to the implementation of transparent, open source code interface for economic models. The possibility of making economic model source code could be positive and progressive for the field; however, several unintended consequences of this system should be first considered before complete implementation of this model. First, there is the concern regarding intellectual property rights that modelers have to their analyses. Second, the open source code could make analyses more accessible to inexperienced modelers, leading to inaccurate or misinterpreted results. We propose several resolutions to these concerns. The field should establish a licensing system of open source code such that the model originators maintain control of the code use and grant permissions to other investigators who wish to use it. The field should also be more forthcoming towards the teaching of cost-effectiveness analysis in medical and health services education so that providers and other professionals are familiar with economic modeling and able to conduct analyses with open source code. These types of unintended consequences need to be fully considered before the field's preparedness to move forward into an era of model transparency with open source code.

摘要

《健康与医学成本效益分析第二小组关于成本效益分析的实施、方法实践及报告的建议》中,关于经济模型透明开源代码接口的实施仍有一些问题未得到解答。公开经济模型源代码对该领域可能具有积极意义且是一种进步;然而,在全面实施此模式之前,应首先考虑该系统的一些意外后果。首先,建模者对其分析拥有的知识产权令人担忧。其次,开源代码可能会使经验不足的建模者更容易获取分析结果,从而导致结果不准确或被误解。我们针对这些问题提出了几种解决方案。该领域应建立开源代码许可制度,以便模型创建者能够控制代码的使用,并向希望使用代码的其他研究者授予许可。该领域还应在医学和卫生服务教育中更积极地开展成本效益分析教学,以使医疗服务提供者和其他专业人员熟悉经济建模并能够使用开源代码进行分析。在该领域准备好迈向开源代码模型透明时代之前,需要充分考虑这些意外后果。

相似文献

1
Finding Resolution for the Responsible Transparency of Economic Models in Health and Medicine.寻求医疗卫生领域经济模型责任透明度的解决方案。
Med Care. 2017 Nov;55(11):915-917. doi: 10.1097/MLR.0000000000000813.
2
Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine.经济模型透明度能否改善医疗服务提供者对成本效益分析的理解?对健康与医学成本效益第二小组提出的权衡进行评估。
Med Care. 2017 Nov;55(11):909-911. doi: 10.1097/MLR.0000000000000810.
3
Can Economic Model Transparency Improve Provider Interpretation of Cost-Effectiveness Analysis? A Response.经济模型透明度能否提高医疗服务提供者对成本效益分析的解读?回应
Med Care. 2017 Nov;55(11):912-914. doi: 10.1097/MLR.0000000000000811.
4
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
5
Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.实现适当的模型透明度:在美国做出基于价值的决策所面临的挑战和潜在解决方案。
Pharmacoeconomics. 2019 Nov;37(11):1321-1327. doi: 10.1007/s40273-019-00832-2.
6
Characterizing the Validity and Real-World Utility of Health Technology Assessments in Healthcare: Future Directions Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling".在医疗保健中描述健康技术评估的有效性和实际效用:对“健康技术的问题与前景:早期健康经济建模的作用”的评论
Int J Health Policy Manag. 2020 Aug 1;9(8):352-355. doi: 10.15171/ijhpm.2019.132.
7
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
8
Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project.开发美国医疗体系的开源模型:开源价值项目的实践经验和当前挑战。
Pharmacoeconomics. 2019 Nov;37(11):1313-1320. doi: 10.1007/s40273-019-00827-z.
9
Reviewing the evidence to inform the population of cost-effectiveness models within health technology assessments.回顾证据,为卫生技术评估中的成本效益模型提供信息。
Value Health. 2013 Jul-Aug;16(5):830-6. doi: 10.1016/j.jval.2013.04.009. Epub 2013 Jun 19.
10
A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling.需要改变!改善决策建模透明度的编码框架。
Pharmacoeconomics. 2019 Nov;37(11):1329-1339. doi: 10.1007/s40273-019-00837-x.

引用本文的文献

1
Development and Validation of the US Diabetes, Obesity, Cardiovascular Disease Microsimulation (DOC-M) Model: Health Disparity and Economic Impact Model.美国糖尿病、肥胖症、心血管疾病微观模拟模型(DOC-M)的开发和验证:健康差异和经济影响模型。
Med Decis Making. 2023 Oct-Nov;43(7-8):930-948. doi: 10.1177/0272989X231196916. Epub 2023 Oct 16.
2
Transparency in Health Economic Modeling: Options, Issues and Potential Solutions.卫生经济建模中的透明度:选择、问题及潜在解决方案。
Pharmacoeconomics. 2019 Nov;37(11):1349-1354. doi: 10.1007/s40273-019-00842-0.
3
Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and Adolescents.
模拟建模和变形建模以支持国家和国际针对儿童和青少年的艾滋病毒政策。
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1(1):S49-S57. doi: 10.1097/QAI.0000000000001749.